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Background: Clostridium difficile infection (CDI) is prevalent in healthcare settings. The
emergence of hypervirulent and antibiotic resistant strains has led to an increase in CDI
incidence and frequent outbreaks. While the main virulence factors are the TcdA and
TcdB toxins, antibiotic resistance is thought to play a key role in the infection by and
dissemination of C. difficile.
Methods: A CDI outbreak involving 12 patients was detected in a tertiary care hospital,
in Lisbon, which extended from January to July, with a peak in February, in 2016. The
C. difficile isolates, obtained from anaerobic culture of stool samples, were subjected to
antimicrobial susceptibility testing with Etest R©strips against 11 antibiotics, determination
of toxin genes profile, PCR-ribotyping, multilocus variable-number tandem-repeat
analysis (MLVA) and whole genome sequencing (WGS).
Results: Of the 12 CDI cases detected, 11 isolates from 11 patients were characterized.
All isolates were tcdA−/tcdB+ and belonged to ribotype 017, and showed high level
resistance to clindamycin, erythromycin, gentamicin, imipenem, moxifloxacin, rifampicin
and tetracycline. The isolates belonged to four genetically related MLVA types, with
six isolates forming a clonal cluster. Three outbreak isolates, each from a different
MLVA type, were selected for WGS. Bioinformatics analysis showed the presence of
several antibiotic resistance determinants, including the Thr82Ile substitution in gyrA,
conferring moxifloxacin resistance, the substitutions His502Asn and Arg505Lys in rpoB
for rifampicin resistance, the tetM gene, associated with tetracycline resistance, and
two genes encoding putative aminoglycoside-modifying enzymes, aadE and aac(6′)-
aph(2′′). Furthermore, a not previously described 61.3 kb putative mobile element was
identified, presenting a mosaic structure and containing the genes ermG, mefA/msrD
and vat, associated with macrolide, lincosamide and streptogramins resistance.
A substitution found in a class B penicillin-binding protein, Cys721Ser, is thought to
contribute to imipenem resistance.
Frontiers in Microbiology | www.frontiersin.org 1 December 2018 | Volume 9 | Article 2994
fmicb-09-02994 December 5, 2018 Time: 10:15 # 2
Isidro et al. Resistance Determinants in C. difficile Outbreak Clone
Conclusion: We describe an epidemic, tcdA−/tcdB+, multidrug resistant clone of
C. difficile from ribotype 017 associated with a hospital outbreak, providing further
evidence that the lack of TcdA does not impair the infectious potential of these strains.
We identified several determinants of antimicrobial resistance, including new ones
located in mobile elements, highlighting the importance of horizontal gene transfer in
the pathogenicity and epidemiological success of C. difficile.
Keywords: Clostridium difficile, multidrug resistant clone, outbreak, resistance determinants, genomic analysis
INTRODUCTION
Clostridium difficile, recently renamed as Clostridioides difficile
(Lawson et al., 2016), infection (CDI), is the main cause
of nosocomial antibiotic-associated diarrhea in developed
countries, and is prevalent in the healthcare setting. CDI
incidence as well as the occurrence of outbreaks has increased
dramatically in the last two decades due to the emergence of
antibiotic resistant and hypervirulent strains (Freeman et al.,
2010; Vindigni and Surawicz, 2015; Isidro et al., 2017). CDI
usually develops in hospitalized elderly individuals when the
protective colon microbiota is disrupted due to previous
antimicrobial therapy (reviewed by Rupnik et al., 2009; Smits
et al., 2016). Most C. difficile toxigenic strains produce two
main virulence factors, the toxins TcdA and TcdB, encoded by
genes located in the pathogenicity locus (PaLoc); some strains
additionally produce a binary toxin, CDT, while others produce
only TcdB (Hunt and Ballard, 2013; Chandrasekaran and Lacy,
2017).
Antibiotic resistance is frequently reported in prevalent
C. difficile strains and is thought to play a major role in
the infection and dissemination of this pathogen, as well as
in the emergence of new types of epidemic clones (Spigaglia,
2016; Isidro et al., 2017). Resistance may be due to different
mechanisms, such as the expression of genes located on mobile
elements or specific mutations in the genes coding for the
antibiotics targets (Brouwer et al., 2011; Isidro et al., 2017).
Here we describe a multidrug resistant clone from PCR
ribotype 017 C. difficile implicated in a CDI outbreak that
occurred between January and July 2016 in two surgery wards in a
hospital from the Lisbon Metropolitan Area. Multilocus variable-
number tandem repeat analysis (MLVA) was used to determine
the genetic relatedness of the strains and whole-genome
sequencing (WGS) to identify determinants of resistance.
MATERIALS AND METHODS
C. difficile Isolates
Following the CDI surveillance program, 11 stool samples
from 11 CDI-positive patients, diagnosed using the C. DIFF
QUIK CHEK COMPLETE R©kit, were collected between January
and July 2016, during an outbreak in a hospital from
the Lisbon Metropolitan Area, and sent to the National
Reference Laboratory for Gastrointestinal Infections, hosted in
the Portuguese National Institute of Health, for laboratory-based
epidemiological surveillance of CDI. As described previously,
stool samples were inoculated onto ChromID C. difficile agar
(bioMérieux, Marcy l’Etoile, France) after ethanol shock and
incubated under anaerobic conditions for 48 h at 37◦C (Santos
et al., 2016). Total DNA was extracted with the Isolate II
Genomic DNA kit (Bioline, London, United Kingdom), followed
by a multiplex PCR to detect the genes gluD, tcdA, tcdB, cdtA
and cdtB (Paltansing et al., 2007; Persson et al., 2008). An
additional PCR was carried out to detect mutations in tcdA
(Kato et al., 1999). Capillary gel-based electrophoresis PCR
ribotyping was performed using Bidet primers, as previously
described (Fawley et al., 2015). Patient’s demographic and clinical
data was collected by the infection control team of the affected
hospital.
Antimicrobial Susceptibility Testing
Minimum inhibitory concentrations (MICs) of chloramphenicol,
clindamycin, erythromycin, gentamicin, imipenem,
metronidazole, moxifloxacin, rifampicin, tetracycline,
tigecycline and vancomycin were determined with Etest
strips (bioMérieux), according to the manufacturer’s
instructions. Plates were incubated under anaerobic
conditions for 48 h at 37◦C. The European Committee
on Antimicrobial Susceptibility Testing (EUCAST)
breakpoints established for C. difficile were used when
available. For the remaining antibiotics, the Clinical and
Laboratory Standards Institute (CLSI) breakpoints were used
(Table 2).
Multilocus Variable-Number
Tandem-Repeat Analysis
Multilocus variable-number tandem-repeat analysis was carried
out following the method developed by van den Berg et al.
to amplify the loci A6, B7, C6, E7, G8, and CDR60 (Van
Den Berg et al., 2007), with an alternative reverse primer
to amplify the locus G8, as previously described (Tanner
et al., 2010). Each locus size was determined by capillary
gel electrophoresis and the corresponding number of repeats
was used to construct a minimum spanning tree using
the summed absolute distance as coefficient. Isolates with a
summed tandem-repeat difference (STRD)≤ 10 were considered
genetically related regardless the number of different loci.
Clonal complexes were defined by a STRD ≤ 2 between two
isolates that were either single or double locus variants of each
other.
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Whole Genome Sequencing and
Bioinformatics Analysis
Three strains (A, B, and K; Figure 1) were selected for WGS
in order to identify putative determinants of resistance and
assess clonal relationship. WGS was performed as previously
described (Isidro et al., 2018). Nextera XT libraries were subjected
to paired-end sequencing on an Illumina Miseq platform
(Illumina Inc., San Diego, CA, United States). After reads’ quality
analysis (FastQC v0.11.51) and improvement, (Trimmomatic
v0.36), draft genome sequences were de novo assembled using
SPAdes (version 3.10.1) (Bankevich et al., 2012) followed by
annotation using the RAST server2 (Aziz et al., 2008). The
PubMLST online platform3 was used for in silico Multilocus
Sequence Typing (MLST) and allele determination. Core-
genome single nucleotide polymorphism (SNP)-based analysis
was performed using Snippy v3.14. Only variant sites with
minimum mapping quality of 60, minimum of > 10 reads
covering the variant position and > 90% reads differing from
the reference genome were considered. Putative antimicrobial
resistance (AMR) genes were identified using both CARD5 and
ResFinder6 (Zankari et al., 2012; Jia et al., 2017). Prophage
sequences were identified using PHASTER7 (Arndt et al., 2016).
BLASTn searches8 against the non-redundant (nr) and wgs
databases were performed to identify the presence (and similarity
level) of determinants of resistance in other available genomes.
The genome of strain M68 from ribotype 017 (Acc. No.
NC_017175) was used as reference. Raw sequence reads of the
three C. difficile isolates subjected to WGS were deposited in
Sequence Read Archive under the Bioproject accession number
PRJNA478136.
Construction of an ermG Inducible Strain
for Heterologous Expression
To place the ermG gene under the control of the anhydro
tetracycline-inducible Ptet promoter, the ermG gene
with its ribosome-binding site (positions −12 to + 793
from the translational start codon) was PCR amplified
using primers ermG850D (5′ GGATTCGGAGAGGTTAT
AATGAACAAAG 3′) and ermG1660R (5′ ATAGTTTAGC
GGCCGCATTTTAACTTATGCTACCCTACC 3′) and genomic
DNA from strain A (Figure 1), isolated in January 2016, from
the first outbreak patient, as the template. The resulting
810 bp-long PCR product was cleaved with EcoRI and
NotI and inserted between the same sites of pAM25, to
yield pMS534. pAM25 is a derivative of pRPF185 from
which the gusA gene was removed (Fagan and Fairweather,
2011). Plasmids pRPF185 and pMS534 were introduced
into E. coli HB101 (RP4) and the resulting strains used to
1http://www.bioinformatics.babraham.ac.uk/projects/fastqc/
2http://rast.nmpdr.org/
3https://pubmlst.org/
4https://github.com/tseemann/snippy
5https://card.mcmaster.ca/
6https://cge.cbs.dtu.dk/services/ResFinder/
7http://www.phaster.ca/
8https://blast.ncbi.nlm.nih.gov/
transfer the plasmids, by conjugation, into C. difficile 6301erm
with selection for thiamphenicol resistance (15 µg/ml) as
described before (Serrano et al., 2016). For induction of
the Ptet promoter, cultures were grown in the presence of
250 µg/ml of anhydro tetracycline (Fagan and Fairweather,
2011).
RESULTS
C. difficile Isolates
A CDI outbreak occurred between January and July 2016 in two
surgery wards of a < 500-bed tertiary care hospital. In 2015,
the hospital registered a CDI incidence of 2 cases per 10,000
patient bed-days, while there were no cases in the two surgery
wards. Twelve cases of nosocomial CDI were detected during
this outbreak, 10 in the cardiothoracic surgery ward and two in
general surgery ward, with the following temporal distribution:
one case in January, seven in February, one in March, one in
April, one in June and one in July. The patients’ age ranged
from 50 to 84 years and 7/12 were male. According to patient’s
hospital medical records, 11 of the 12 patients had received
two or more classes of antibiotics in the 3 months prior to the
diagnosis. Patient’s demographic and clinical characteristics are
summarized in Table 1. The isolates were recovered from 11 of
the 12 cases and all belonged to ribotype 017. All were tcdA-
negative, carrying a previously described ∼1800 bp deletion in
tcdA (Kato et al., 1999), tcdB-positive and did not carry the cdtA
and cdtB genes coding for the binary toxin CDT.
Antimicrobial Susceptibility
All isolates showed high level resistance to clindamycin
(>256 mg/L), erythromycin (>256 mg/L), gentamicin
(>256 mg/L), imipenem (>32 mg/L), moxifloxacin (>32 mg/L),
rifampicin (>32 mg/L), and tetracycline (16 mg/L), being
susceptible to metronidazole, vancomycin, chloramphenicol and
tigecycline (Table 2).
TABLE 1 | Characteristics and clinical data of patients with Clostridium difficile
infection associated with an outbreak.
Patients (n = 12) characteristics Number (%)
%Males 7 (58.3%)
Mean age in years (interquartile range) 71 (64–81)
Ward
Cardiothoracic surgery 10 (83.3%)
General surgery 2 (16.7%)
Hospital admission during the 6 previous months 4 (20%)
Antimicrobial exposure within 3-months before CDI diagnosis 11 (91.7%)
Classes of antibiotics
Aminoglycosides 7 (58.3%)
Vancomycin 7 (58.3%)
Carbapenems 3 (25%)
Penicillins associated with clavulanic acid or tazobactam 3 (25%)
Fluoroquinolones 2 (16.7)
Cephalosporins 1 (8.3%)
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FIGURE 1 | MLVA profiles and minimum spanning tree for Clostridium difficile PCR ribotype 017 isolates. For the minimum spanning tree, unique MLVA types are
represented by circles, and the summed tandem-repeat differences (STRD) between isolates given by the numbers between the circles. Gray shading indicates a
clonal complex (isolates with a STRD of ≤2).
MLVA
Four MLVA types were identified among the studied isolates
(Figure 1), with only one type displaying two loci differences
from the remaining. Loci A6, B7, E7, and CDR60 were invariable;
C6 was the most variable locus while G8 only differed in the most
recent isolate (K). This isolate, from July, displayed the higher
distance from the others, with a 10 tandem-repeat difference
in loci C6 and G8 from the first isolate, dated from January.
All isolates were genetically related and six of them, which had
been collected between January 28th and March 1st, constituted
a clonal complex (Figure 1).
Whole-Genome Sequencing Results
The 11 isolates shared a high genetic proximity, as determined
by MLVA, and therefore only three, representing the outbreak
period and belonging to different MLVA types, isolates A (from
January), B (from February, the peak period) and K (from July),
were selected for WGS (Figure 1). Data analysis showed the three
strains belonged to the multilocus sequence type (MLST) clade 4,
ST37. The pathogenicity locus (PaLoc) showed a complete tcdB
gene (PubMLST allele 9), and a disrupted tcdA with a 1.8 kb
deletion at the 3′ end and an early stop codon at amino acid 47,
which is typical of ribotype 017. Regarding the accessory genes of
the PaLoc, no mutations were found in tcdE, coding a holin-like
protein necessary for toxin secretion, or in the putative negative
regulator of toxin production tcdC (PubMLST allele 7). The
transcriptional regulator tcdR, which has a frameshift mutation
in the reference strain M68 (locus CDM68_RS03600) due to a
deletion at nucleotide 165 that leads to an early stop codon, is
in frame, and predicted as functional, in our strains.
Core-genome SNP-based analysis, using the genome of strain
M68 as reference, identified a total of 35 single nucleotide variants
TABLE 2 | Antimicrobial susceptibility and determinants of resistance of the 11
Clostridium difficile ribotype 017 isolates characterized in this study.
Antibiotic R
breakpoint
(mg/L)
MIC
(mg/L)
Phenotype
(S/R)
Genetic
determinant
of
resistance
Clindamycin >4a >256 R ermG
Erythromycin ≥8a >256 R ermG
Chloramphenicol ≥32a 3–6 S –
Gentamicin ≥16b >256 R aac(6′)-
aph(2′ ′) and
aadEd
Imipenem ≥16a >32 R Cys721Ser in
PBP3e
Metronidazole >2c 0.125–1.5 S –
Moxifloxacin >4c >32 R Thr82Ile in
GyrA
Rifampicin >0.004c >32 R His502Asn
and
Arg505Lys in
RpoB
Tetracycline ≥16a 16 R tetM
Tigecycline >0.25c 0.023–
0.047
S –
Vancomycin >2c 0.5–0.75 S –
aBreakpoints according to the Clinical and Laboratory Standards Institute (CLSI)
interpretative values for anaerobes. bBreakpoints according to the Clinical and
Laboratory Standards Institute (CLSI) interpretative values for Staphylococcus
spp. cBreakpoints defined by the EUCAST guidelines (European Committee on
Antimicrobial Susceptibility Testing). dPutative mechanism of resistance in other
bacterial genera. ePutative mechanism of resistance.
(SNVs), of which 33 distinguished the strain M68 from the
outbreak strains, being that isolates A and B had no differences
between each other and isolate K had 2 SNPs distinguishing
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it from isolates A and B, which is consistent with nosocomial
transmission.
WGS data revealed the presence of several determinants
of resistance (Table 2). Two genes encoding putative
aminoglycoside-modifying enzymes, termed aadE
(aminoglycoside 6-adenylyltransferase) and aac(6′)-Ie-
aph(2′′)-Ia (bifunctional aminoglycoside N-acetyltransferase
AAC(6′)-Ie/aminoglycoside O-phosphotransferase APH(2′′)-
Ia), were found in the sequenced isolates. BLASTn search
against the nr database showed that aadE and aac(6′)-Ie-
aph(2′′)-Ia, which are homologous to the loci CDM68_RS08230
and CDM68_RS08245, respectively, in the reference strain
M68, are not frequent in C. difficile genomes. On the
other hand, they are common in other bacterial genera.
The gene aadE is found with 100% coverage and identity
in several Campylobacter coli genomes, as well as in
a few genomes of Campylobacter jejuni, Streptococcus
agalactiae and Enterococcus faecalis, among others. The
gene aac(6′)-Ie-aph(2′′)-Ia found in our isolates is present
with 100% coverage and identity in many Staphylococcus spp.
genomes, but also Enterococcus spp. and Campylobacter spp,
among others.
The tetracycline resistance determinant tetM (PubMLST allele
15), homologous to the locus CDM68_RS01945 in strain M68,
was also present in our isolates and was identified in the
conjugative transposon Tn916 (Acc. No. KC414929).
The substitution Thr82Ile in GyrA (PubMLST allele 35),
which is responsible for fluoroquinolones resistance, and two
mutations in rpoB, leading to the amino acid substitutions
His502Asn and Arg505Lys (PubMLST allele 20), both known to
be associated with rifampicin resistance, were present in the three
sequenced isolates.
Furthermore, we found the mutation 2162G > C in the
homolog of locus CDM68_RS05670, which codes for a penicillin-
binding protein (PBP), PBP3 (Isidro et al., 2018). This mutation,
which leads to the amino acid substitution Cys721Ser, occurs in
the PBP transpeptidase domain, the target of carbapenems action
(Papp-Wallace et al., 2011).
An ermG gene was identified in a cluster of genes associated
with macrolide, lincosamide and streptogramins (MLS)
resistance that also included the genes mefA and msrD, both
associated with macrolide efflux resistance, and vat, coding for a
Streptogramin A acetyltransferase (Figure 2). This cluster of MLS
resistance genes was found in a 61.3 kb element that interrupts
the 23S rRNA (uracil-C(5))-methyltransferase encoding gene
(homolog of locus CDM68_RS02190 in strain M68) and shows
multiple traits associated with mobile elements likely acquired
by horizontal gene transfer (HGT) (Figure 2). This region
exhibits a mosaic structure, composed of (i) a Type I restriction-
modification (RM) system, with genes coding for the subunits R
(restriction), S (specificity) and M (DNA methyltransferase), (ii)
an intact prophage of around 49 Kb, as detected by PHASTER,
and (iii) the aforementioned cluster of MLS resistance genes,
followed by a IS66 family transposase (Figure 2). Three other
C. difficile genomes deposited in Genbank present this putative
mobile element with >99.9% coverage and identity: the non-
toxinogenic strain Z31 (ribotype 009) and strains 7499-CF/ST37
and VL_0008, both belonging to ST37 (Acc. Nos. CP013196,
MPFV01000002, and CZWM01000001, respectively). Another
strain, VL_0387 (Acc. No. FALC01000010), also from ST37,
contains a highly similar element (also >99.9% sequence
coverage and identity) but in which the region containing the
ermG and the transposase is inverted, when comparing to the
isolates from this study. Seven other C. difficile draft genomes
(Acc. Nos. FANQ01000006, FAKJ01000001, FADL01000009,
FACQ01000001, CZZV01000006, CZYY01000001,
CZXE01000001) harbor a similar element (86% coverage
and 98.4% sequence identity) that does not contain the MLS
resistance portion, which points to the mosaic origin of this
element. Likewise, the genome of C. difficile strain M120
(ribotype 078) exhibits a ∼40 kb region (Acc. No. NC_017174,
genome position 426527–466056) with 62.8% coverage and
90.6% sequence identity with the element present in our strains,
while not containing the flanking RM system nor the MLS
resistance cluster.
The 61.3 kb putative mobile element has homology with
other non-C. difficile genomes. For instance, the genomic region
spanning the RM system and the prophage has a high homology
with two genomes of Thermoanaerobacter sp., covering 70% of
the element with 88% sequence identity (Acc. Nos. NC_014538
and NC_010320). The proteins coded by the RM system are
common in the class Clostridia and are also found in Enterococcus
cecorum. The prophage region is found with 89% sequence
identity, covering 62% of the element, in the genome of
Clostridium bornimense strain M2/40T (Acc. No. HG917868)
and the cluster of MLS resistance genes is found in three
genomes of Enterococcus cecorum with 98.5% sequence identity,
covering 9% of the element (Acc. Nos. CP010060, CP010061 and
CP010064).
The genes mefA and msrD present in this element are found
with >99% coverage and >95% sequence identity in many
bacterial species, most of which are Streptococcus spp., mainly
S. pneumoniae and S. pyogenes, but also in E. cecorum, Neisseria
gonorrhoeae and Acinetobacter junii, among other species. The
vat gene is present in a few C. difficile genomes and is also found
with >96% coverage and >91% sequence identity in several
E. cecorum, E. faecium and Streptococcus suis genomes.
The ermG gene present in this element is found in
multiple species with a sequence coverage and identity ≥99%,
including Lysinibacillus sphaericus (Acc. Nos. NG_047827 and
M15332), E. cecorum (mentioned above), E. faecium (Acc. No.
CP003351), Bacteroides spp. (Acc. Nos. NG_047828, L42817,
NG_047829.1 and AJ557257) and nine C. difficile genomes
(Acc. Nos. CP013196, MPFV01000002, FALC01000010,
CZWM01000001, FALZ01000014, FAIU01000023,
FAES01000003, FACO01000021, FACG01000010), among
which is the non-toxinogenic strain C. difficile Z31.
The 61.3 kb ermG-containing region is absent in reference
strain M68 (Figure 3). However, the conjugative transposon
Tn6194 harboring the ermB gene ( the gene most commonly
associated with MLS resistance in C. difficile), is present in strain
M68, while being absent in all the isolates from this study.
The primer pair ermG-F (5′ TCACATAGAAAAAATAAT
GAATTGCATAAG 3′) and ermG-R (5′ CGATACAAATTGT
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FIGURE 2 | Genetic organization of the novel Clostridium difficile putative mobile element harboring the ermG gene. Restriction-modification system genes are
shown in purple, prophage genes are shown in blue and the genes associated with macrolides, lincosamides and streptogramines resistance are indicated in
orange. The transposase is shown in green and the interrupted gene coding for a 23S rRNA (uracil-C(5))-methyltransferase is shown in black. Genes coding for
hypothetical proteins are shown in gray.
TCGAAACTAATATTGT 3′) was used to amplify a 652 bp
amplicon of ermG and confirmed its presence in the remaining
outbreak isolates.
The element containing the ermG is located in a region
showing evidence of other HGT events (Figure 3), such as
prophages and putative conjugative transposons (CTn). Overall,
PHASTER identified three complete, one questionable and four
incomplete prophages (data not shown). All, except for the
complete prophage harboring the ermG-element, are found
in strain M68. One of the incomplete prophages is located
72 kb downstream the homolog of locus CDM68_RS02190.
The 72 kb region between this incomplete prophage and the
ermG-containing element shows a high homology with the
43.5 kb CTn5 element present in C. difficile strain 630 (Acc.
No. AM180355, genome position 2137789–2181291). This 72 kb
region covers 90% of CTn5 with 99% sequence identity but
in the isolates of this study it is interrupted by two genetic
insertions of 8 and 22 kb (Figure 3). This 72 kb region is
present in the strain BJ08 (Acc. No. CP003939), but in M68
strain it is shorter, lacking the two aforementioned insertions
(42 kb; genome position 407967–449991), and more similar to
the CTn5 of C. difficile strain 630 (Figure 3). The 8 kb insertion
shows high homology to a Campylobacter coli plasmid (Acc. No.
CP017026; 88% coverage, 95% sequence identity), while ∼10 kb
of the 22 kb insertion has 99.9% sequence identity with regions of
three genomes, namely Flavonifractor sp., Enterococcus faecium
and C. difficile (Acc. Nos. NFHA01000028, LNMU01000054 and
MPDX01000112, respectively).
Confirmation of MLS Resistance
Mediated by ermG
The ermG-inducible C. difficile 6301erm strain was subjected
to antimicrobial susceptibility testing by diffusion gradient with
Etest strips against erythromycin and clindamycin. Confirming
that the expression of ermG confers resistance to MLS antibiotics,
the MICs of erythromycin and clindamycin were both of
>256 mg/L in the C. difficile 6301erm conjugant expressing the
ermG, when comparing with the MICs observed for C. difficile
6301erm ermG− strain (0.75 and 1 mg/L, respectively).
DISCUSSION
In the present work, we studied a multidrug resistant TcdA-
negative C. difficile clone from ribotype 017 implicated in a
CDI outbreak and identified several determinants of resistance
through WGS data analysis. Two novel mechanisms of resistance
were described here, namely, the ermG gene, which mediates the
resistance to MLS antibiotics and is carried by a putative mobile
element exhibiting a mosaic structure, and a mutation in a PBP
that is likely associated with imipenem resistance.
Ribotype 017 is the most prevalent TcdA-negative C. difficile
strain and has been considered a recently emerging type, being
associated with outbreaks in some European countries (Van Den
Berg et al., 2004; Drudy et al., 2007; Goorhuis et al., 2011; Cairns
et al., 2015). In a few countries, such as Poland, China or Korea,
ribotype 017 is the most common ribotype overall (Pituch et al.,
2011; Collins et al., 2013). As such, the lack of one of C. difficile
main pathogenicity factors (TcdA) does not seem to affect the
spreading or infectious potential of these strains.
The described ribotype 017 clone presented resistance
to seven classes of antibiotics (Table 2), among which
fluoroquinolones, MLS, tetracycline and rifampicin, for
which resistance has been described in ribotype 017 in several
studies (Barbut et al., 2007; Spigaglia et al., 2011; Dong
et al., 2013; Freeman et al., 2015). However, resistance to
carbapenems, and its underlying mechanism, is still poorly
studied in C. difficile. According to a pan-European study,
most clinical isolates in Europe are susceptible to imipenem,
although ribotype 027 showed elevated MICs compared
to other ribotypes (Freeman et al., 2015). Similarly to
another clone of ribotype 017 that we described recently
(Isidro et al., 2018), the clone characterized in the present
study also showed a high-level resistance to imipenem (MIC
>32 mg/L).
Resistance to carbapenems in gram-positive bacteria is
often associated with single-point mutations in the vicinity of
the active site of the PBPs transpeptidase domain, which is
carbapenems main target (Davies et al., 2008; Zapun et al.,
2008; Papp-Wallace et al., 2011). In this work, we found the
mutation Cys721Ser in the transpeptidase domain of PBP3,
which is one of the two mutations, along with Ala555Thr
in PBP1, that we had previously found in another ribotype
017 imipenem-resistant clone (Isidro et al., 2018). In this
previous work, we proposed that these mutations mediate
resistance by reducing the binding affinity of imipenem to
PBPs. Both the present clone and the one described in
the previous study presented a MIC of >32 mg/L but it
is possible that their levels of resistance differ at higher
concentrations of imipenem, depending on the presence of one
or the two mutations, respectively. More studies are therefore
needed to fully understand this mechanism of resistance and
Frontiers in Microbiology | www.frontiersin.org 6 December 2018 | Volume 9 | Article 2994
fmicb-09-02994 December 5, 2018 Time: 10:15 # 7
Isidro et al. Resistance Determinants in C. difficile Outbreak Clone
FIGURE 3 | Genetic context of the ermG-containing putative mobile element. Genetic context of the novel element containing the ermG gene in the strains from the
present study (A) and comparison of this region with the genome of the reference strain M68 (accession number NC_017175) (B). The darker region represents the
homology with the CTn5 element present in strain 630 (accession number AM180355); the light gray regions interrupting this CTn5-like element are not present in
strain 630. The two large insertions in the CTn5-like element and the novel ermG-containing element differ the strains in this study from strain M68.
determine the contribution of each mutation to the resistance
phenotype.
Antibiotic pressure can lead to the selection of resistance and
promotes the development and spread of resistant strains (Davies
and Davies, 2010). Moreover, CDI shows seasonal variation with
a higher incidence in winter months, when there is an increase
in both hospital occupancy rates and antibiotic consumption
due to respiratory infections (Polgreen et al., 2010; Gilca et al.,
2012; Brown et al., 2013). Interestingly, in the present study,
carbapenems were the most consumed antibiotics in the outbreak
ward, with the hospital also reporting a peak of carbapenems
consumption during the last trimester of 2015 (data not shown).
Altogether, these conditions might have led to the selection and
spread of this imipenem-resistant clone, and subsequently to the
outbreak, with the first case occurring in January 2016.
Resistance to MLS antibiotics in C. difficile is usually due
to ribosomal methylation mediated by the rRNA adenine
N-6-methyltransferase encoded by ermB, and also, but less
frequently, by the chloramphenicol-florfenicol resistance gene,
cfr, which encodes a 23S rRNA methyltransferase that confers
resistance to linezolid (Candela et al., 2017). Both these genes
are carried by mobile genetic elements such as conjugative
transposons (Spigaglia, 2016). The C. difficile isolates in the
present study were all highly resistant to clindamycin and
erythromycin but neither ermB nor cfr were found by WGS.
Instead, the ermG gene was found in the genome of all 11 isolates.
Additionally, the genes mefA, msrD and vat were also found
immediately upstream of ermG. The gene mefA, firstly identified
in Streptococcus pyogenes, mediates macrolides resistance by
efflux and is common in Streptococcus spp. and amongst Gram-
positive bacteria in general. The gene msrD is associated with
the genetic elements carrying mefA in Streptococcus spp., and can
confer the macrolides efflux phenotype in S. pneumoniae (Clancy
et al., 1996; Daly et al., 2004; Poole, 2005). However, neither mefA
nor msrD confer resistance to lincosamides or streptogramins.
Here, we demonstrated that ermG expression alone is sufficient
to confer a high level of resistance to clindamycin and to
erythromycin upon heterologous expression in the ribotype 012
strain 6301erm.
The ermG was located in a novel putative genetic mobile
element with a mosaic structure that is not present in the closest
reference strain M68 from ribotype 017. This element contained
a RM system, a prophage and a cluster of four MLS resistance
genes that showed high sequence identity with elements found
in other bacterial genus, which is consistent with transmission
to C. difficile by HGT. This new element is found in very few
C. difficile available genomes that, however, have no phenotype
data available. Although further investigation is warranted, the
fact that one of these genomes is from a non-toxigenic strain from
ribotype 009 (Pereira et al., 2016) provides strong evidence for the
transmission of this ermG-containing element between C. difficile
strains and highlights the importance of non-toxigenic strains as
carriers of resistance determinants.
Several studies have showed evidence of interspecies HGT
(Bloemendaal et al., 2010; Goren et al., 2010; Juhas, 2015;
von Wintersdorff et al., 2016) and C. difficile has also been
suggested as a reservoir of resistance genes that might be
transferred to other species in the human gut (Johanesen et al.,
2015). Consistently, our results show a high degree of sequence
identity between determinants of resistance found in C. difficile
and other relevant human pathogens, As an example, in this
work we found two genes encoding aminoglycoside-modifying
enzymes, aadE and aac(6′)-Ie-aph(2′′)-Ia, that seem to have a low
prevalence in C. difficile but are widespread in Enterococcus spp.,
Campylobacter spp., Staphylococcus spp. or Streptococcus spp.
Anaerobes, such as C. difficile, however, are naturally resistant
to aminoglycosides (which explains the high MICs generally
observed) (Khanafer et al., 2018) and hence the presence of these
genes may not directly correlate with the resistance phenotype.
Nonetheless, the potential transfer of these genes to other species
in which they might contribute to aminoglycoside resistance
cannot be disregarded. Overall, these results underline the
importance of HGT events in the evolution of C. difficile and also
point to its potential as a resistance reservoir in the human gut
(He et al., 2010; Johanesen et al., 2015). This particular multidrug
resistant clone of ribotype 017, harboring such a relevant number
of determinants of antimicrobial resistance in mobile elements,
may likely trigger the dissemination of these determinants in
Frontiers in Microbiology | www.frontiersin.org 7 December 2018 | Volume 9 | Article 2994
fmicb-09-02994 December 5, 2018 Time: 10:15 # 8
Isidro et al. Resistance Determinants in C. difficile Outbreak Clone
clinical settings as well as in the community and the environment,
and thus, it should be targeted by an active laboratory and
epidemiological surveillance.
In summary, in this study we described a C. difficile
multidrug resistant clone implicated in a hospital outbreak
presenting new resistant determinants that seemingly promoted
the spreading success of this clone. Our data show that
C. difficile is continually evolving through HGT and indicate
that antibiotic selective pressure continues to be a major driving
force in the development and emergence of new epidemic
strains.
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